04/02/2025
5:20 PM | Actinium Pharmaceuticals (Issuer)
O'Loughlin Steve (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
5:20 PM | Actinium Pharmaceuticals (Issuer)
SETH SANDESH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
5:21 PM | Actinium Pharmaceuticals (Issuer)
Shetty Ajit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
5:21 PM | Actinium Pharmaceuticals (Issuer)
Nicholson, C. David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
5:22 PM | Actinium Pharmaceuticals (Issuer)
Almenoff June Sherie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
5:22 PM | Actinium Pharmaceuticals (Issuer)
Chell Jeffrey W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
5:22 PM | Actinium Pharmaceuticals (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
3:30 PM | Actinium Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:57 PM | Actinium Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2024
12:33 PM | Actinium Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/08/2024
5:51 PM | Actinium Pharmaceuticals (Subject)
Bigger Capital, LLC (Filed by)
| Form SC 13G/A | |
11/06/2024
6:30 AM | Actinium Pharmaceuticals (Filer)
| Form ARS | |
11/05/2024
4:00 PM | Actinium Pharmaceuticals (Filer)
| Form DEF 14A | |
11/05/2024
4:05 PM | Actinium Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
4:10 PM | Actinium Pharmaceuticals (Issuer)
Almenoff June Sherie (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/05/2024
4:12 PM | Actinium Pharmaceuticals (Issuer)
Almenoff June Sherie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2024
10:47 AM | Actinium Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G | |
11/04/2024
10:10 AM | Actinium Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
08/05/2024
6:30 AM | Actinium Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Buy ATNM Stock Free ATNM Stock Alerts